These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 3686097)
1. Economics of essential drugs schemes: the perspectives of the developing countries. Wang'ombe JK; Mwabu GM Soc Sci Med; 1987; 25(6):625-30. PubMed ID: 3686097 [TBL] [Abstract][Full Text] [Related]
2. The economics of essential drug programmes. Smith GT Soc Sci Med; 1987; 25(6):621-4. PubMed ID: 3686096 [TBL] [Abstract][Full Text] [Related]
3. [An analysis of the pharmaceuticals market in Vietnam]. Simonet D Sante; 2001; 11(3):155-60. PubMed ID: 11641078 [TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical policies for the Third World--whose responsibility? Lancet; 1983 Jul; 2(8342):144. PubMed ID: 6134987 [TBL] [Abstract][Full Text] [Related]
5. The multinational drug companies in Zaire: their adverse effect on cost and availability of essential drugs. Glucksberg H; Singer J Int J Health Serv; 1982; 12(3):381-7. PubMed ID: 7118328 [TBL] [Abstract][Full Text] [Related]
6. When medicine becomes a disease. Arabia; 1986 Mar; 5(55):32-6. PubMed ID: 12340711 [TBL] [Abstract][Full Text] [Related]
7. TRIPS, pharmaceuticals, developing countries, and the Doha "solution". Sykes AO Chic J Int Law; 2002; 3(1):47-68. PubMed ID: 15709299 [No Abstract] [Full Text] [Related]
8. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha. 't Hoen E Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298 [No Abstract] [Full Text] [Related]
9. Reprivatizing pharmaceutical supplies in Africa. Turshen M J Public Health Policy; 2001; 22(2):198-225. PubMed ID: 11469153 [TBL] [Abstract][Full Text] [Related]
10. Bib Pharma Monopoly: Why Consumers Keep Landing on "Park Place" and How the Game is Rigged. Levy MS Am Univ Law Rev; 2016; 66(1):247-303. PubMed ID: 28225582 [TBL] [Abstract][Full Text] [Related]
11. The development of the Essential Drugs Program and implications for self-reliance in Tanzania. Munishi GK J Clin Epidemiol; 1991; 44 Suppl 2():7S-14S. PubMed ID: 2045845 [TBL] [Abstract][Full Text] [Related]
12. Medical technology and developing countries: the case of Brazil. Banta HD Int J Health Serv; 1986; 16(3):363-73. PubMed ID: 3733305 [TBL] [Abstract][Full Text] [Related]
13. Cost containment through pharmaceutical procurement: a Caribbean case study. Huff-Rousselle M; Burnett F Int J Health Plann Manage; 1996; 11(2):135-57. PubMed ID: 10172681 [TBL] [Abstract][Full Text] [Related]
14. Sparks fly over patents and vital drugs at world health assembly. Kapp C Lancet; 2003 May; 361(9372):1873. PubMed ID: 12788578 [No Abstract] [Full Text] [Related]
16. Drug production with a social conscience, the experience of Gonoshasthaya Pharmaceuticals. Chetley A Dev Dialogue; 1985; (2):94-107. PubMed ID: 12341051 [TBL] [Abstract][Full Text] [Related]
17. Globalization of the pharmaceutical industry and the growing dependency of developing countries: the case of Turkey. Semin S; Güldal D Int J Health Serv; 2008; 38(2):379-98. PubMed ID: 18459286 [TBL] [Abstract][Full Text] [Related]
18. Public drug procurement: the lessons from a drug tender in a teaching hospital of a transition country. Milovanovic DR; Pavlovic R; Folic M; Jankovic SM Eur J Clin Pharmacol; 2004 May; 60(3):149-53. PubMed ID: 15057496 [TBL] [Abstract][Full Text] [Related]
19. Aid conditionalities, international Good Manufacturing Practice standards and local production rights: a case study of local production in Nepal. Brhlikova P; Harper I; Subedi M; Bhattarai S; Rawal N; Pollock AM Global Health; 2015 Jun; 11():25. PubMed ID: 26072308 [TBL] [Abstract][Full Text] [Related]